We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.85 | 2.80 | 2.90 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 2.85 | 2.75 | 2.75 | 1,516,809 | 15:51:32 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.66 | 22.1M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/11/2024 | 14:22 | ALNC |  Shield Therapeutics shares up on strong October sales |
| 21/11/2024 | 07:00 | UK RNS | Shield Therapeutics PLC Business Update |
| 29/10/2024 | 14:34 | ALNC | Shield Therapeutics shares slide as it expands financing arrangement |
| 29/10/2024 | 07:00 | UK RNS | Shield Therapeutics PLC Q3 Trading Update |
| 25/9/2024 | 06:00 | UK RNS | Shield Therapeutics PLC Results from Phase 3 paediatric study |
| 04/9/2024 | 10:39 | ALNC | Shield Therapeutics revenue triples, but cost rises widen annual loss |
| 04/9/2024 | 06:00 | UK RNS | Shield Therapeutics PLC Interim results |
| 27/8/2024 | 18:34 | ALNC | TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up |
| 27/8/2024 | 06:00 | UK RNS | Shield Therapeutics PLC ACCRUFeR® Approved by Health Canada |
| 14/8/2024 | 06:00 | UK RNS | Shield Therapeutics PLC Notice of interim results |
1 Year Shield Therapeutics Chart |
Intraday Shield Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
